A draft guidance document provides recommendations for submitting bioavailability information in investigational new drug and new drug applications. FDA published draft guidance on Feb. 25, 2019 on ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
MUMBAI, India, and BRIDGEWATER, N.J., Sept. 3, 2025 /PRNewswire/ -- Today, OmniActive Health Technologies (OmniActive) announced results from two newly published, peer-reviewed clinical studies in ...
Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence. Twelve patients with refractory solid tumors were enrolled onto this three-period ...
The US Food and Drug Administration (FDA) on Friday finalized guidance for sponsors who wish to request a waiver of an in vivo bioavailability (BA) and/or bioequivalence (BE) study requirements for ...
Health Canada has released a new draft guidance document proposing to allow the waiver of bioavailability studies in support of marketing authorization applications for immediate-release, ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Objective: Iron fortification of wheat flour is widely used. In most cases, elemental iron powders are utilized as fortificants due to their lower cost and few, if any, sensory problems. However, ...
HELSINKI, Jan. 5, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance enhancing company, today announced it had completed the First Subject First Visit (FSFV) in a trial ...
(MENAFN- GlobeNewsWire - Nasdaq) Dublin, April 07, 2025 (GLOBE NEWSWIRE) -- The "Bioavailability and Bioequivalence Studies submitted in NDAs and INDs" training has been added to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results